0001787352-26-000004.txt : 20260814
0001787352-26-000004.hdr.sgml : 20260814
20260814113528
ACCESSION NUMBER: 0001787352-26-000004
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering
FILED AS OF DATE: 20260814
DATE AS OF CHANGE: 20260814
EFFECTIVENESS DATE: 20260814
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nuclein, LLC
CENTRAL INDEX KEY: 0001787352
ORGANIZATION NAME:
EIN: 821705145
STATE OF INCORPORATION: TX
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-588046
FILM NUMBER: 261278118
BUSINESS ADDRESS:
STREET 1: 8305 CROSS PARK DR
CITY: AUSTIN
STATE: TX
ZIP: 78754
BUSINESS PHONE: 512-879-3301
MAIL ADDRESS:
STREET 1: 8305 CROSS PARK DR
CITY: AUSTIN
STATE: TX
ZIP: 78754
D/A
1
primary_doc.xml
X0708
D/A
LIVE
0001787352
Nuclein, LLC
8305 CROSS PARK DR
AUSTIN
TX
TEXAS
78754
512-879-3301
TEXAS
None
None
Limited Liability Company
true
Alan
Blake
8305 Cross Park Dr
Austin
TX
TEXAS
78754
Executive Officer
Director
Richard
Crockett
8305 Cross Park Dr
Austin
TX
TEXAS
78754
Director
William
Cunningham
8305 Cross Park Dr
Austin
TX
TEXAS
78754
Director
Douglas
Bryant
8305 Cross Park Dr
Austin
TX
TEXAS
78754
Director
Sanjay
Chandra
8305 Cross Park Dr
Austin
TX
TEXAS
78754
Director
H.
David
Shockley
8305 Cross Park Dr
Austin
TX
TEXAS
78754
Director
Walter
Narajowski
8305 Cross Park Dr
Austin
TX
TEXAS
78754
Director
Jeffrey
Stukuls
8305 Cross Park Dr
Austin
TX
TEXAS
78754
Executive Officer
Biotechnology
Decline to Disclose
- 06b
true
0001787352-26-000003
2026-06-04
false
true
false
0
16114842
9253488
6861354
false
15
0
0
0
false
Nuclein, LLC
Alan Blake
Alan Blake
Chief Executive Officer
2026-08-14